期刊文献+

糖皮质激素规律治疗与成人免疫性血小板减少症近期复发的关系 被引量:3

Regularation of glucocorticoid therapy more than six months can effectively reduced the recent recurrence in patients with immune thrombocytopenia
下载PDF
导出
摘要 目的:探讨免疫性血小板减少症(ITP)患者糖皮质激素规律治疗与复发率的关系,进一步规范ITP的激素治疗。方法:选取门诊和住院ITP患者共101例,血小板<30×109/L伴出血者予糖皮质激素治疗,按医嘱并逐渐减量组称为常规治疗组,自行停用或随意减量组称为非常规治疗组,比较2组的复发率及复发时间。结果:中位随访时间63个月。非常规治疗组复发率81.8%,显著高于常规治疗组12.9%(P<0.01);其复发相对危险度是正规治疗组的20.7倍;且平均复发时间4.8个月,显著短于常规治疗组44.8个月(P<0.05)。结论:糖皮质激素规律减量治疗6个月以上可明显降低ITP的复发。 Objective:To discuss the relationship between the regular therapy with glucocorticoid and the re- lapse rate in immune thrombocytopenia (ITP)patients,and to further standardize the glucocorficoid treatment of ITP.Methods:One hundred and one patients who were diagnosed as ITP admitted into hospital or outpatients were enrolled in the study,the patients were treated with prednisone when the platelet count was less than 20~30x109/L and absence of bleeding,according to the prescription and gradually reduced prednisone dosage groups known as the regular treatment groups,otherwise,reducded dosage or withdrawal the prednisone ran- domly called unregular treatment groups.Results:There were significant differences of relapse rate between the unregular and regular treatment groups (81.8% vs 12.8%,P〈0.01),the odd ratio of the relapse was 20.7 times in unregular than regular treatment groups.Also,there were significant differences of average relapse times be- tween the unregular and regular treatment groups (4.8months vs 44.8months,P〈0.05).Conclusion:Regular of glucocorticoid therapy more than six months can effectively reduced the recent relapse rate in ITP patients.
出处 《中日友好医院学报》 2014年第2期85-88,共4页 Journal of China-Japan Friendship Hospital
关键词 免疫性血小板减少症 糖皮质激素 糖皮质激素受体 血小板膜糖蛋白 复发率 immune thrombocytopenia glucocorticoid glucocortieoid receptor platelet membrane glycoprotein relapse rate
  • 相关文献

参考文献18

  • 1成人原发免疫性血小板减少症诊治的中国专家共识(修订版)[J].中华血液学杂志,2011,32(3):214-216. 被引量:206
  • 2杨仁池.免疫性血小板减少症的命名、定义与疗效评价的标准化——关于ITP国际工作组报告的解读[J].中华血液学杂志,2009,30(3):215-216. 被引量:41
  • 3Cines DB,Blanchette ~S.lmmune thrombocytopenic purpura [J].N Engl J Meal,2002,346:995-1008.
  • 4George JN,el-Harake MA,Raskob GE.Chronic idiopathic thrombocytopenic purpura[J].N Engl J Med, 1994,331 : 1207- 1211.
  • 5George JN,Woolf SH,Raskob GE,et al.Idiopathic thrombo- cytopenic purpura:a practice guideline developed by explicit methods for the American Society of Hematology[J].Blood, 1996,88 : 3-40.
  • 6Portielje JE,Westendorp RG,Kluin-Nelemans HC,et al.Mor- bidity and mortality in adults with idiopathic thrombocy- topenic purpura[J].Blood, 2001,97 : 2549-2554.
  • 7Johnsen J.Pathogenesis in immune thromboeytopenia:new in- sights [J].Hematology Am Soc Hematol Edue Program, 2012,2012:306-312.
  • 8Li J,van der Wal DE,Zhu I,et al.Fc-independent phagocy- tosis:implications for IVIG and other therapies in immune- mediated thrombocytopenia [J].Cardiovasc Hematol Disord Drug Targets,2013,13:50-58.
  • 9Jansen AJ,Josefsson EC,Rumjantseva V,et al.Desialylation accelerates platelet clearance after refrigeration and initiates GPlbcmetalloproteinase-mediated cleavage in mice[J].Blood,2012,1(19):1263-1273.
  • 10Zeng Q,Zha I,Tao l,et al.Relative efficacy of steroid ther- apy in immune thrombocytopenia mediated by anti-platelet GPIIb/Ⅲ a versus GP Icl antibodies [J].Am J Hematol. 2012.87:206.208.

二级参考文献2

共引文献253

同被引文献13

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部